NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free LABD Stock Alerts $8.53 +0.37 (+4.53%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$8.32▼$8.7550-Day Range$6.05▼$11.0352-Week Range$5.72▼$29.92Volume13.58 million shsAverage Volume15.38 million shsMarket Capitalization$101.68 millionAssets Under Management$92.84 millionDividend Yield1.06%Net Expense Ratio1.00% Stock AnalysisStock AnalysisChartHoldingsOwnershipStock AnalysisChartHoldingsOwnership Get Direxion Daily S&P Biotech Bear 3x Shares alerts: Email Address About Direxion Daily S&P Biotech Bear 3x SharesThe Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.Read More LABD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LABD ETF News HeadlinesMarch 21, 2024 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0664March 2, 2024 | msn.comSOXS, ARKB and LABD among weekly ETF moversMay 8, 2024 | Unstoppable Prosperity (Ad)RSVP: Charles Payne’s Cash Flow WorkshopAre you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.July 21, 2023 | msn.comLABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best AvoidedJune 22, 2023 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0998June 22, 2023 | msn.com5 Factors Why Inverse ETFs May Rule in 2H23March 1, 2023 | msn.com5 Best Inverse-Leveraged ETFs of FebruaryFebruary 24, 2023 | finance.yahoo.comThis Year's Most Shorted ETFsMay 8, 2024 | Unstoppable Prosperity (Ad)RSVP: Charles Payne’s Cash Flow WorkshopAre you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.February 15, 2023 | finance.yahoo.com5 Least-Hurt Biotech ETFs of the Last WeekSee More Headlines Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings24 Fund Statistics Assets Under Management$92.84 million Average Daily Volume$14.43 million Discount/Premium-0.01% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume2,105 Put Options127 Call Options1,978 Short Interest2,300,000 shs Miscellaneous Outstanding Shares11,920,000Beta-3.24 Creation Unit50,000 Creation Fee$250.00 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> Direxion Daily S&P Biotech Bear 3x Shares ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.54%0.51%0.51%Other Expenses0.26%0.40%0.54%0.64%0.58%Total Expense1.01%0.72%0.70%0.74%0.70%Fee Waiver-0.01%-0.53%-0.55%-0.68%-0.57%Net Expense1.00%0.60%0.60%0.58%0.58% Direxion Daily S&P Biotech Bear 3x Shares (LABD) HoldingsTop 10 LABD HoldingsDREYFUS GOVT CASH MAN INSHolding Weight: 62.15%GOLDMAN FINL SQ TRSRY INST 506Holding Weight: 50.80%DREYFUS TRSRY SECURITIES CASH MGMTHolding Weight: 12.84%GOLDMAN SACHS FIN GOV 465 INSTITUTHolding Weight: 10.68%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -28.84%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -37.00%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -37.68%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -54.09%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -56.93%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -85.45%Full Holdings Details Similar ETFsProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBProShares Ultra Health CareNYSEARCA:RXLSimplify Propel Opportunities ETFNYSEARCA:SURISPDR S&P Health Care Services ETFNYSEARCA:XHSSimplify Health Care ETFNYSEARCA:PINKInstitutional OwnershipHeadlands Technologies LLCBought 16,082 shares on 5/8/2024Ownership: 0.238%Virtu Financial LLCBought 29,033 shares on 2/26/2024Ownership: 10.240%IMC Chicago LLCBought 105,127 shares on 2/9/2024Ownership: 1.600%View All Institutional Transactions LABD ETF - Frequently Asked Questions How have LABD shares performed in 2024? Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $9.69 at the beginning of 2024. Since then, LABD shares have decreased by 12.0% and is now trading at $8.53. View the best growth stocks for 2024 here. What does LABD invest in? Direxion Daily S&P Biotech Bear 3x Shares is a equity fund issued by Direxion. LABD focuses on health care investments and follows the S&P Biotechnology Select Industry Index. The fund's investments total to approximately $92.84 million assets under management. What is the management fee for Direxion Daily S&P Biotech Bear 3x Shares? Direxion Daily S&P Biotech Bear 3x Shares' management fee is 0.75% and has other expenses of 0.26%. However, LABD has a fee waiver of -0.01% to reimburse the expenses. The net expense ratio for LABD is 1.00%. When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? Direxion Daily S&P Biotech Bear 3x Shares's stock reverse split on Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bear 3x Shares investors own include Direxion Daily S&P Biotech Bull 3x Shares (LABU), Micron Technology (MU), Intel (INTC), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Pfizer (PFE), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and ProShares UltraPro Short QQQ (SQQQ). Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders? Direxion Daily S&P Biotech Bear 3x Shares' stock is owned by a variety of retail and institutional investors. Top institutional investors include Headlands Technologies LLC (0.24%). How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:LABD) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.